Supplementary Fig. S1.

Hematoxylin and eosin staining of nine tumor samples subjected to exome sequencing. The nine ESCC samples subjected to exome sequencing were examined using hematoxylin and eosin staining. Tumor cell content of each sample (as indicated by patient ID) was evaluated and reviewed by two pathologists independently. The magnification for all of the images was 400×.